Fig. 6

Crude proportions of reliever-only therapies in Dutch primary care (2010–2021) from the PHARMO data network for females by age group. SAMA (short-acting muscarinic antagonist), SABA (short-acting beta-agonist), SABA-SAMA (combination of SABA and SAMA). Shaded areas represent 95% confidence intervals